Alx Oncology Holdings Inc (ALXO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8301 -0.0013 (-0.16%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8701 +0.0400 (+4.82%) 17:58 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 0 | 0 | 0 | 527 | 655 |
| Cost of Goods | N/A | 0 | N/A | 479 | 596 |
| Gross Profit | N/A | 0 | N/A | 48 | 59 |
| Operating Expenses | 14,208 | 17,825 | 9,809 | 11,314 | 5,897 |
| Operating Income | -14,208 | -17,825 | -9,809 | -10,787 | -5,242 |
| Interest Expense | 0 | 0 | 226 | 219 | 215 |
| Other Income | 23 | -767 | -111 | -305 | 7 |
| Pre-tax Income | -14,185 | -18,592 | -10,146 | -11,311 | -5,450 |
| Income Tax | 0 | 182 | 35 | 20 | 4 |
| Net Income Continuous | -14,185 | -18,774 | -10,181 | -11,331 | -5,454 |
| Net Income | $-14,185 | $-18,774 | $-10,181 | $-11,331 | $-5,454 |
| EPS Basic Total Ops | -0.35 | 4.38 | -0.36 | -4.41 | -2.37 |
| EPS Basic Continuous Ops | -0.35 | 3.18 | -0.34 | -3.58 | -1.74 |
| EPS Diluted Total Ops | -0.35 | 4.38 | -0.36 | -4.41 | -2.37 |
| EPS Diluted Continuous Ops | -0.35 | 3.18 | -0.34 | -3.58 | -1.74 |
| EBITDA(a) | $-14,203 | $-17,738 | $-9,686 | $-10,595 | $-5,021 |